Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Comparison of Peripheral Blood Stem Cell Mobilization for Multiple Myeloma Patients over 70 Years of Age with Younger Patients

Ning Dong, MD, David S Siegel, MD PhD, Phyllis McKiernan, Noa Biran, MD, Alan P Skarbnik, MD, David H. Vesole, MD PhD, Andrew L. Pecora, MD, Scott D. Rowley, MD, Michele L. Donato, MD

Blood (2018) 132 (Supplement 1): 4554.

https://doi.org/10.1182/blood-2018-99-117498

Published: 2018

Journal Articles

Classical Hodgkin Lymphoma Patients Have an Increased Incidence of Idiopathic Acquired Aplastic Anemia

Taylor Linaburg, BSc, Adam R. Davis, MD, Noelle V. Frey, MD, Daniel J. Landsburg, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Yimei Li, PhD, Yuliya Borovskiy, MS, Timothy S. Olson, MD PhD, Adam Bagg, MD, Elizabeth O. Hexner, MD MS, Daria V. Babushok, MD PhD

Blood (2018) 132 (Supplement 1): 5098.

https://doi.org/10.1182/blood-2018-99-110032

Published: 2018

Journal Articles

Azacitidine Response Prediction in MDS Patients with NGS Data Using a Computational Biology Modeling (CBM) Based Clinical Decision Support System

Lubomir Minarik, MD, Leylah M. Drusbosky, PhD, Taher Abbasi, MS, MBA, Karina Vargova, MBBS, MSc, Vojtech Kulvait, PhD, Anna Jonasova, MD, Neeraj Kumar Singh, B.Tech, Yashaswini S Ullal, B.E, Sirisha Narayanabhatia, M.Sc., Aktar Alam, BCA, Kunal Ghosh Roy, M.Sc., Ashish Choudhary, M.Sc., Shireen Vali, PhD, Christopher R. Cogle, MD, Tomas Stopka, MD PhD

Blood (2018) 132 (Supplement 1): 3087.

https://doi.org/10.1182/blood-2018-99-114610

Published: 2018

Journal Articles

A Prospective Observational Study Evaluating Sarcopenia By Using the Bioelectrical Impedance Analysis in Elderly Patients with Hematologic Malignancies

Takahiro Kamiya, Kota Mizuno, Shinji Ogura, Chisako Ito, Yuriko Fujita, Yoshinobu Aisa, Tomonori Nakazato, MD PhD

Blood (2018) 132 (Supplement 1): 4851.

https://doi.org/10.1182/blood-2018-99-114545

Published: 2018

Journal Articles

Functional Predictors of Chemotherapy Toxicity in Elderly Lymphoma Patients: A Prospective Pilot Study

Anca Prica, MD, Vinita Dhir, Manjula Maganti, MSc, Vishal Kukreti, MD, John Kuruvilla, MD, Michael Crump

Blood (2018) 132 (Supplement 1): 4843.

https://doi.org/10.1182/blood-2018-99-115400

Published: 2018

Journal Articles

GMI-1271 Improves Efficacy and Safety of Chemotherapy in R/R and Newly Diagnosed Older Patients with AML: Results of a Phase 1/2 Study

Daniel J. DeAngelo, MD, Brian A Jonas, MD PhD, Jane L. Liesveld, MD, Dale L. Bixby, Anjali S. Advani, MD, Paula Marlton, MBBS, Michael O'Dwyer, MD, John L Magnani, PhD, Helen M. Thackray, MD, Pamela S. Becker, MD PhD

Blood (2017) 130 (Supplement 1): 894.

https://doi.org/10.1182/blood.V130.Suppl_1.894.894

Published: 2017

Journal Articles

Infections in Patients with Myelodysplastic Syndrome. Looking for the Escape Clause!

Cesar Gentille Sanchez, MD, Qian Qin, MD, Kai Sun, MD, Joe Ensor, PhD, Mamta Puppala, MSc, Stephen Wong, PhD, Ibrahim F. Ibrahim, MD, Lawrence Rice, MDBA, Sai Ravi Kiran Pingali, MD, Swami P. Iyer, MD

Blood (2017) 130 (Supplement 1): 1694.

https://doi.org/10.1182/blood.V130.Suppl_1.1694.1694

Published: 2017

Journal Articles

Treatment-Related Morbidity and Mortality Associated with Remission Induction in Adolescent and Young Adult (AYA) Versus Young Adult Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Cory Michael Vela, PharmD, Viet Q. Ho, PharmD, RPh, BCOP, Justina Ofori Frimpong, PharmD, BCOP, Bryan Brinda, Pharm.D., Timothy George, Pharm.D., BCOP, Kendra L. Sweet, MD, Eric Padron, MD, David Sallman, MD, Alan F List, MD, Jeffrey E. Lancet, MD, Rami S. Komrokji, MD

Blood (2016) 128 (22): 5167.

https://doi.org/10.1182/blood.V128.22.5167.5167

Published: 2016

Journal Articles

Comparison of Vincristine Pharmacokinetics (PK) in Adolescent/Young Adult (AYA) Versus Younger Patients Defined By Tanner Stage during Treatment for Acute Lymphoblastic Leukemia (ALL)

Leidy L Isenalumhe, MD, Ashley S. Margol, MD, Stan Louie, Pharm.D., PhD, FASHP, Michael Neely, MD MSc, FCP, Richard Sposto, PhD, Jemily Malvar, MS, David Robert Freyer, DO, MS

Blood (2015) 126 (23): 3725.

https://doi.org/10.1182/blood.V126.23.3725.3725

Published: 2015

Journal Articles

Age Adjusted Telomere Length Decreases Following Treatment for Pediatric Acute Lymphoblastic Leukemia, but Does Not Predict Toxicity

Pasquale M Barbaro, MBBS FRACP FRCPA, Marion Mateos, MBBS (Hons) BSc (MD FRACP, Luciano Dalla-Pozza, MB BS FRACP, Anthea Ng, BAppSc, MSc, Glenn M Marshall, MBBS, MD FRACP, Jodie E Giles, Rosemary Sutton, Rebecca Dagg, BSc (Hons), Loretta Lau, MBBS, MMed, PhD FRACP, Hilda A Pickett, BSc (Hons) PhD, Roger R Reddel, BSc (MD MBBS PhDFRACP FAA

Blood (2015) 126 (23): 4984.

https://doi.org/10.1182/blood.V126.23.4984.4984

Published: 2015

Journal Articles

Gender and Obesity Do Not Impact Survival in Diffuse Large B-Cell Lymphoma: Justification for Full Weight-Based Chemotherapy Dosing in All Patients

Anna Nikonova, MD

Blood (2015) 126 (23): 2721.

https://doi.org/10.1182/blood.V126.23.2721.2721

Published: 2015

Journal Articles

Delays in Start of Intensification Therapy Are Common for Adults with Acute Lymphoblastic Leukemia, and Are Associated with Decreased Survival in Patients Who Undergo Allogeneic Stem Cell Transplant (SCT)

Anita J. Kumar, MDMS, Phyllis A. Gimotty, PhD, Joel Gelfand, MDMS, Georgina Buck, Jacob M. Rowe, MD, Anthony H Goldstone, MD, Adele Fielding, MB BS, PhD, David I Marks, Mark Litzow, Elisabeth Paietta, PhD, Hillard M. Lazarus, Martin S. Tallman, MD, Selina M. Luger, MD, Alison W. Loren, MDMS

Blood (2014) 124 (21): 208.

https://doi.org/10.1182/blood.V124.21.208.208

Published: 2014

Journal Articles

Anti-CD19 CAR T Cells Administered after Low-Dose Chemotherapy Can Induce Remissions of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma

James N Kochenderfer, MD, Robert Somerville, PhD, Lily Lu, PhD, Alex Iwamoto, B.S., James C Yang, MD, Christopher Klebanoff, MD, Udai Kammula, MD, Richard M Sherry, MD, Shi Victoria, M.S., Constance Yuan, MD PhD, Steven Feldman, PhD, Tatyana Feldman, MD, Andre Goy, MD MS, Kathleen E Morton, RN, Mary Ann Toomey, RN, Steven A. Rosenberg, MD PhD

Blood (2014) 124 (21): 550.

https://doi.org/10.1182/blood.V124.21.550.550

Published: 2014

Journal Articles

Geriatric Assessment in Older Adults with Newly Diagnosed Multiple Myeloma

Tanya M Wildes, MD MSCI, Brittany Depp, Ravi Vij, MD, Keith Stockerl-Goldstein, MD, Graham Colditz, MD DrPH

Blood (2014) 124 (21): 1286.

https://doi.org/10.1182/blood.V124.21.1286.1286

Published: 2014

Journal Articles

Long-Term Overall Survival In Diffuse Large B-Cell Lymphoma With Bone Marrow Involvement Patients After High-Dose Chemotherapy Plus Autologous Stem Cells Transplantation

Olga A. Gavrilina, MD, Evgeny E. Zvonkov, MD, PhD, Nelly G. Gabeeva, MD, PhD, Eduard G. Gemdjian, PhD, Vladimir I. Vorobyev, MD, Sergey K. Kravchenko, MD, PhD, Valeri G. Savchenko, MD, PhD

Blood (2013) 122 (21): 2169.

https://doi.org/10.1182/blood.V122.21.2169.2169

Published: 2013

Journal Articles

Outpatient Administration Of Hyper-CVAD Chemotherapy For Acute Lymphoblastic Leukaemia / Lymphoma Is Safe and Associated With Similar Toxicity Compared To Inpatient Delivery

Emad Uddin Abro, Kirk Morris, Georgina Hodges, Jason P Butler, Cameron Curley, Elango Subramonia Pillai, Glen A Kennedy

Blood (2013) 122 (21): 5017.

https://doi.org/10.1182/blood.V122.21.5017.5017

Published: 2013

Journal Articles

Radiation Therapy In Peripheral T-Cell Lymphoma Of The Head and Neck

Annemarie T. Fernandes, MD, Jakub Svoboda, MD, Sunita D. Nasta, MD, Lynn D. Wilson, MD, John P. Plastaras, MD PhD

Blood (2013) 122 (21): 1795.

https://doi.org/10.1182/blood.V122.21.1795.1795

Published: 2013

Journal Articles

Bendamustine, Bortezomib and Dexamethasone (BBD) As First-Line Treatment of Patients with Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy: Toxicity Comparison of Two Dose Schedules

Jesus G. Berdeja, MD, Michael R. Savona, MD, FACP, James Essell, MD, Patrick Murphy, MD, Luis Chu, MD, Ralph V. Boccia, MD, Edward Arrowsmith, MD, MPH, Ian W. Flinn, MD, PhD

Blood (2012) 120 (21): 4047.

https://doi.org/10.1182/blood.V120.21.4047.4047

Published: 2012

Journal Articles

Chemotherapy Toxicity Related to Non-Alcoholic Fatty Liver Disease (NAFLD) in an Adolescent with Pre-B Cell Acute Lymphoblastic Leukemia

Chatchawin Assanasen, MD, Rony Skaria, MD, Maria G. Falcon, MD, Victor Saldivar, MD

Blood (2012) 120 (21): 4303.

https://doi.org/10.1182/blood.V120.21.4303.4303

Published: 2012

Journal Articles

Post-Transplant Lymphoproliferative Disorder in Lung Transplant Recipients – a Shift Lo Late Onset Disease

Eli Muchtar, MD, Liat Vidal, MD, Ron Ram, MD, Ronit Gurion, MD, Yivgenia Rosenblat, MD, Ilana Bakal, RN, Mordechai Kramer, MD, FCCP, Ofer Shpilberg, MD, MPH

Blood (2012) 120 (21): 5075.

https://doi.org/10.1182/blood.V120.21.5075.5075

Published: 2012

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Comparison of Peripheral Blood Stem Cell Mobilization for Multiple Myeloma Patients over 70 Years of Age with Younger Patients

Classical Hodgkin Lymphoma Patients Have an Increased Incidence of Idiopathic Acquired Aplastic Anemia

Azacitidine Response Prediction in MDS Patients with NGS Data Using a Computational Biology Modeling (CBM) Based Clinical Decision Support System

A Prospective Observational Study Evaluating Sarcopenia By Using the Bioelectrical Impedance Analysis in Elderly Patients with Hematologic Malignancies

Functional Predictors of Chemotherapy Toxicity in Elderly Lymphoma Patients: A Prospective Pilot Study

GMI-1271 Improves Efficacy and Safety of Chemotherapy in R/R and Newly Diagnosed Older Patients with AML: Results of a Phase 1/2 Study

Infections in Patients with Myelodysplastic Syndrome. Looking for the Escape Clause!

Treatment-Related Morbidity and Mortality Associated with Remission Induction in Adolescent and Young Adult (AYA) Versus Young Adult Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Comparison of Vincristine Pharmacokinetics (PK) in Adolescent/Young Adult (AYA) Versus Younger Patients Defined By Tanner Stage during Treatment for Acute Lymphoblastic Leukemia (ALL)

Age Adjusted Telomere Length Decreases Following Treatment for Pediatric Acute Lymphoblastic Leukemia, but Does Not Predict Toxicity

Gender and Obesity Do Not Impact Survival in Diffuse Large B-Cell Lymphoma: Justification for Full Weight-Based Chemotherapy Dosing in All Patients

Delays in Start of Intensification Therapy Are Common for Adults with Acute Lymphoblastic Leukemia, and Are Associated with Decreased Survival in Patients Who Undergo Allogeneic Stem Cell Transplant (SCT)

Anti-CD19 CAR T Cells Administered after Low-Dose Chemotherapy Can Induce Remissions of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma

Geriatric Assessment in Older Adults with Newly Diagnosed Multiple Myeloma

Long-Term Overall Survival In Diffuse Large B-Cell Lymphoma With Bone Marrow Involvement Patients After High-Dose Chemotherapy Plus Autologous Stem Cells Transplantation

Outpatient Administration Of Hyper-CVAD Chemotherapy For Acute Lymphoblastic Leukaemia / Lymphoma Is Safe and Associated With Similar Toxicity Compared To Inpatient Delivery

Radiation Therapy In Peripheral T-Cell Lymphoma Of The Head and Neck

Bendamustine, Bortezomib and Dexamethasone (BBD) As First-Line Treatment of Patients with Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy: Toxicity Comparison of Two Dose Schedules

Chemotherapy Toxicity Related to Non-Alcoholic Fatty Liver Disease (NAFLD) in an Adolescent with Pre-B Cell Acute Lymphoblastic Leukemia

Post-Transplant Lymphoproliferative Disorder in Lung Transplant Recipients – a Shift Lo Late Onset Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only